130 related articles for article (PubMed ID: 2971653)
21. Inability of a mouse cell line transformed to produce biologically active recombinant human insulin-like growth factor I (IGF-I) to respond to exogenously added IGF-I.
Cascieri MA; Hayes NS; Kelder B; Kopchick JJ; Chicchi GG; Slater EE; Bayne ML
Endocrinology; 1988 Apr; 122(4):1314-20. PubMed ID: 2964361
[TBL] [Abstract][Full Text] [Related]
22. Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells.
Furlanetto RW
Endocrinology; 1988 May; 122(5):2044-53. PubMed ID: 2966062
[TBL] [Abstract][Full Text] [Related]
23. Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties.
Koistinen R; Huhtala ML; Stenman UH; Seppälä M
Clin Chim Acta; 1987 May; 164(3):293-303. PubMed ID: 3109787
[TBL] [Abstract][Full Text] [Related]
24. Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts.
Martin JL; Willetts KE; Baxter RC
J Biol Chem; 1990 Mar; 265(7):4124-30. PubMed ID: 2154495
[TBL] [Abstract][Full Text] [Related]
25. Purification and characterization of an insulin-like growth factor II variant from human plasma.
Hampton B; Burgess WH; Marshak DR; Cullen KJ; Perdue JF
J Biol Chem; 1989 Nov; 264(32):19155-60. PubMed ID: 2553732
[TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts.
Cara JF; Stuart CA; Furlanetto RW
Endocrinology; 1988 Sep; 123(3):1341-7. PubMed ID: 2969801
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor I binding and receptor kinase in red and white muscle.
Zorzano A; James DE; Ruderman NB; Pilch PF
FEBS Lett; 1988 Jul; 234(2):257-62. PubMed ID: 2968920
[TBL] [Abstract][Full Text] [Related]
28. Purification and characterization of three molecular forms of insulin-like growth factor II from human Cohn paste IV.
Straczek J; Heulin MH; Chenut AM; Lasbennes A; Geschier C; Belleville F; Nabet P
J Chromatogr; 1990 Nov; 532(2):237-48. PubMed ID: 2084122
[TBL] [Abstract][Full Text] [Related]
29. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.
Mohan S; Bautista CM; Wergedal J; Baylink DJ
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8338-42. PubMed ID: 2479022
[TBL] [Abstract][Full Text] [Related]
30. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity.
Clemmons DR; Cascieri MA; Camacho-Hubner C; McCusker RH; Bayne ML
J Biol Chem; 1990 Jul; 265(21):12210-6. PubMed ID: 1695626
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells.
Cara JF; Rosenfield RL
Endocrinology; 1988 Aug; 123(2):733-9. PubMed ID: 2969325
[TBL] [Abstract][Full Text] [Related]
32. Interaction of ovine somatomedin-C/IGF-I and IGF-I with specific IGF-I receptors on cultured muscle-derived fibroblasts.
Dodson MV; Mathison BA; Hossner KL
Acta Endocrinol (Copenh); 1987 Oct; 116(2):186-92. PubMed ID: 2958982
[TBL] [Abstract][Full Text] [Related]
33. The structural basis for insulin-like growth factor I receptor high affinity binding.
Tollefsen SE; Thompson K
J Biol Chem; 1988 Nov; 263(31):16267-73. PubMed ID: 2972706
[TBL] [Abstract][Full Text] [Related]
34. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor.
Bayne ML; Applebaum J; Underwood D; Chicchi GG; Green BG; Hayes NS; Cascieri MA
J Biol Chem; 1989 Jul; 264(19):11004-8. PubMed ID: 2472386
[TBL] [Abstract][Full Text] [Related]
35. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid.
Koistinen R; Kalkkinen N; Huhtala ML; Seppälä M; Bohn H; Rutanen EM
Endocrinology; 1986 Apr; 118(4):1375-8. PubMed ID: 2419121
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of the receptor for insulin-like growth factor I.
Morgan DO; Jarnagin K; Roth RA
Biochemistry; 1986 Sep; 25(19):5560-4. PubMed ID: 2946318
[TBL] [Abstract][Full Text] [Related]
37. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts.
Kiess W; Haskell JF; Lee L; Greenstein LA; Miller BE; Aarons AL; Rechler MM; Nissley SP
J Biol Chem; 1987 Sep; 262(26):12745-51. PubMed ID: 2957378
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man.
Hardouin S; Hossenlopp P; Segovia B; Seurin D; Portolan G; Lassarre C; Binoux M
Eur J Biochem; 1987 Dec; 170(1-2):121-32. PubMed ID: 2961563
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.
Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM
Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077
[TBL] [Abstract][Full Text] [Related]
40. A simple and efficient scheme for the purification of insulin-like growth factor II from human bone matrix extract.
Mohan S
Growth Factors; 1990; 2(4):267-71. PubMed ID: 2337472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
